digital currency trading platforms, Top stories

An earthquake with a magnitude of 5.6 occurred in the sea area northeast of Fiji. According to the measurement of the European and Mediterranean Earthquake Center, at 13: 51 local time on December 12th, a magnitude of 5.6 earthquake occurred in the sea area 478 kilometers northeast of Suva, Fiji (15.201 degrees south latitude and 178.282 degrees west longitude) with a focal depth of 10 kilometers.Shibor reported 1.4820% overnight, down 4.6 basis points; In 7 days, shibor reported 1.6350%, down 8.7 basis points; In three months, shibor reported 1.7400%, down 0.4 basis points.An earthquake with a magnitude of 5.6 occurred in the sea area northeast of Fiji. According to the measurement of the European and Mediterranean Earthquake Center, at 13: 51 local time on December 12th, a magnitude of 5.6 earthquake occurred in the sea area 478 kilometers northeast of Suva, Fiji (15.201 degrees south latitude and 178.282 degrees west longitude) with a focal depth of 10 kilometers.

Wang Xiaochuan Baichuan Intelligent has set up a technology company in Ningbo with a number of AI businesses. According to enterprise investigation, recently, Ningbo Baichuan Ronghui Technology Co., Ltd. was established with Wang Xiaochuan as the legal representative and a registered capital of 70 million US dollars. Its business scope includes artificial intelligence dual-creation service platform, artificial intelligence theory and algorithm software development, artificial intelligence basic software development, artificial intelligence general application system, artificial intelligence public data platform and artificial intelligence public service platform technical consulting service. Equity penetration shows that the company is wholly owned by BAICHUAN AI (HK) LIMITED.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Shennong Group has set up a new trading subsidiary in Guangxi. The enterprise search APP shows that recently, Guangxi Shennong Haiyun Trading Co., Ltd. was established, with the legal representative of He Xinyang and the registered capital of 10 million yuan. Its business scope includes: electronic product sales; Non-metallic minerals and products sales; Building materials sales, etc. Enterprise equity penetration shows that the company is wholly owned by Shennong Group.

Lu Kang led a delegation to visit the United States and had an in-depth exchange of views with people from all walks of life on Sino-US relations. From December 1 to 7, Lu Kang, Vice Minister of the International Liaison Department of the CPC Central Committee, led a delegation to visit the United States. In Washington, new york, and San Francisco, Lu Kang met with officials from the White House and the State Council, members of Congress, and relevant people from business circles, think tanks, media, universities, societies, enterprises, etc., and exchanged in-depth views on Sino-US relations. (official website of the International Liaison Department)FTSE China A50 index futures rose 1%.According to sources, Hamas handed over a list of hostages to be released, including Americans.